Popular

To capitalize on this yoga growth LifeApps Digital Media, Inc. (OTCQB- LFAP), a provider of fitness related content for the mobile media market has introduced exciting yoga-centric product platforms.

Plandaí Biotechnology, Inc. (OTCQB – PLPL - $0.48 – Spec Buy) has made significant strides in recent months as it nears an inflection point which will migrate the Company from the development phase to the product commercialization phase.

This partnership is a critical step for Nuvilex and confirms the Company’s status as a well-regarded player in the cancer treatment development segment.

Earlier this week, Plandaí Biotechnology, Inc. (OTCQB – PLPL - $0.50 – Spec Buy) recently released landmark news that after further review, paves the way for the formulation of ingredients with tremendous bioavailability to be used in a whole host of products, including anti-aging and weight loss.

The LifeApps media platform is driving a new market frontier where the amateur athlete or health conscious consumer can meet and gain knowledge from the high profile athlete while simultaneously benefiting the superstar athlete and his or her own brand.

As the Company closes the large-scale deals and books revenue, INSCOR’s valuation will be raised and it is likely that other contracts could follow shortly thereafter, making 1Q13 perhaps an even greater performing quarter than the first major revenue-driven period, 4Q13.

With its ground-breaking, patented sensor technology, Flexpoint Sensor Systems is poised to broadly deploy its products for use in a whole host of applications.